7-118234433-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_019644.4(ANKRD7):c.182C>T(p.Thr61Ile) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000954 in 1,573,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019644.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD7 | NM_019644.4 | c.182C>T | p.Thr61Ile | missense_variant, splice_region_variant | 2/7 | ENST00000265224.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD7 | ENST00000265224.9 | c.182C>T | p.Thr61Ile | missense_variant, splice_region_variant | 2/7 | 1 | NM_019644.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000906 AC: 2AN: 220740Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 120118
GnomAD4 exome AF: 0.00000985 AC: 14AN: 1420862Hom.: 0 Cov.: 28 AF XY: 0.00000708 AC XY: 5AN XY: 706278
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.182C>T (p.T61I) alteration is located in exon 2 (coding exon 2) of the ANKRD7 gene. This alteration results from a C to T substitution at nucleotide position 182, causing the threonine (T) at amino acid position 61 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at